Over-the-counter medications include anti-allergy, indigestion, heartburn, and acid reflux treatments.
Glenmark Pharmaceuticals Ltd announced that its fully owned subsidiary Glenmark Pharmaceuticals Inc., USA (Glenmark) has acquired the approved Abbreviated New Drug Applications (ANDAs) for Famotidine Tablets USP, 10 mg and 20 mg (OTC), Cetirizine Hydrochloride Tablets USP, 5 mg and 10 mg (OTC), Lansoprazole Delayed-Release Capsules USP, 15 mg (OTC) and Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 per cent (OTC) in the United States from Wockhardt Limited. Sanjeev Krishan, President, Glenmark Pharmaceuticals Inc, USA, commented "Our acquisition of these ANDAs represents the continued expansion of our business into the OTC market here in the United States and our commitment to ensuring patients have access to high-quality, affordable medicines."
Glenmark
